Janet Middle
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
- Hematology top 5%
- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
Papers in
-
- COVID-19 Clinical Research Studies 6
- Antimicrobial Resistance in Staphylococcus 1
-
- Erythropoietin and Anemia Treatment 3
- Iron Metabolism and Disorders 3
- Co-authors
- William A. Parker (1 shared paper)Heather M. Judge (1 shared paper)Justin Lee (1 shared paper)Robert F. Storey (1 shared paper)
- Journals
- The Lancet (10 papers)European Heart Journal (1 paper)Platelets (1 paper)Journal of Cardiac Failure (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
Janet Middle
12 papers receiving 2.4k citations
Janet Middle's Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 1.4k
- Hematology 244
- Applied Microbiology and Biotechnology 42
- Pathology and Forensic Medicine 212
- Cardiology and Cardiovascular Medicine 239
Countries citing papers authored by Janet Middle
This map shows the geographic impact of Janet Middle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Middle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Middle more than expected).
Fields of papers citing papers by Janet Middle
This network shows the impact of papers produced by Janet Middle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Middle. The network helps show where Janet Middle may publish in the future.
Co-authors
The 4 scholars most cited alongside Janet Middle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial Hit paper breakdown → | 2022 | 275 |
| 5 | Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Hit paper breakdown → | 2019 | 269 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 7 | 2021 | 213 | |
| 8 | 2017 | 165 | |
| 9 | 2019 | 99 | |
| 10 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 11 | 2024 | 30 | |
| 12 | 2023 | 4 | |
| 13 | 2025 | 0 |
About Janet Middle
Janet Middle is a scholar working on Infectious Diseases, Hematology, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Genetics, having authored 13 papers that have together received 2.5k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Erythropoietin and Anemia Treatment (3 papers), Iron Metabolism and Disorders (3 papers), Cardiac Ischemia and Reperfusion (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Connective tissue disorders research (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Infectious Diseases (1.4k citations), Hematology (244 citations), Applied Microbiology and Biotechnology (42 citations), Pathology and Forensic Medicine (212 citations) and Cardiology and Cardiovascular Medicine (239 citations). Janet Middle has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include William A. Parker, Heather M. Judge, Justin Lee and Robert F. Storey. Their work appears in journals such as The Lancet, European Heart Journal, Platelets and Journal of Cardiac Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.